We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

115 hedge funds and large institutions have $377M invested in Spectrum Pharmaceuticals Inc in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 41

1% more capital invested

Capital invested by funds: $374M → $377M (+$3.07M)

3% less funds holding

Funds holding: 118115 (-3)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

48% less call options, than puts

Call options by funds: $1.88M | Put options by funds: $3.62M

Holders
115
Holders Change
-3
Holders Change %
-2.54%
% of All Funds
3.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
43
Reduced
41
Closed
15
Calls
$1.88M
Puts
$3.62M
Net Calls
-$1.74M
Net Calls Change
-$312K
Name Holding Trade Value Shares
Change
Change in
Stake
FCBT
51
First Citizens Bank & Trust
North Carolina
$638K +$644K +72,069 New
Renaissance Technologies
52
Renaissance Technologies
New York
$615K +$514K +57,500 +478%
VOYA Investment Management
53
VOYA Investment Management
Georgia
$600K -$630K -70,584 -51%
New York State Teachers Retirement System (NYSTRS)
54
New York State Teachers Retirement System (NYSTRS)
New York
$597K -$21.4K -2,400 -3%
PAMU
55
Pictet Asset Management (UK)
United Kingdom
$588K -$336K -37,600 -36%
State Board of Administration of Florida Retirement System
56
State Board of Administration of Florida Retirement System
Florida
$585K
Swiss National Bank
57
Swiss National Bank
Switzerland
$555K +$20.5K +2,300 +4%
IG
58
ING Group
Netherlands
$520K
TPSF
59
Texas Permanent School Fund
Texas
$500K +$1.31K +147 +0.3%
Comerica Bank
60
Comerica Bank
Texas
$498K -$12.5K -1,400 -2%
Citigroup
61
Citigroup
New York
$489K +$230K +25,749 +87%
GIA
62
Gargoyle Investment Advisor
New Jersey
$488K +$492K +55,130 New
SGA
63
Sector Gamma AS
Norway
$443K
MLICM
64
Metropolitan Life Insurance Company (MetLife)
New York
$435K
NFA
65
Nationwide Fund Advisors
Ohio
$434K -$13K -1,459 -3%
AIG
66
American International Group
New York
$418K +$21.4K +2,401 +5%
WMSA
67
Weiss Multi-Strategy Advisers
New York
$396K +$400K +44,800 New
ASRS
68
Arizona State Retirement System
Arizona
$377K -$42K -4,700 -10%
BA
69
BlackRock Advisors
Delaware
$366K +$30.3K +3,389 +9%
Citadel Advisors
70
Citadel Advisors
Florida
$337K +$100K +11,197 +42%
Bank of America
71
Bank of America
North Carolina
$333K -$356K -39,805 -51%
DekaBank Deutsche Girozentrale
72
DekaBank Deutsche Girozentrale
Germany
$321K +$22.3K +2,500 +7%
ProShare Advisors
73
ProShare Advisors
Maryland
$296K -$269K -30,154 -47%
IIM
74
Ironwood Investment Management
Massachusetts
$286K +$6.13K +686 +2%
Public Employees Retirement Association of Colorado
75
Public Employees Retirement Association of Colorado
Colorado
$281K

SPPI Hedge Fund Activity: Q4 2013 in Review

115 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2013, worth a combined $377M — up 0.82% from $374M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SPPI and 12 opened new positions — a net loss of 3 holders — while 41 trimmed existing stakes and 43 added.

The largest buyer was Royal Bank of Canada, adding an estimated $10.4M. The largest seller was D.E. Shaw & Co, cutting an estimated $9.31M.

  • 115 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2013, down from 118 in Q3 2013.
  • Funds reported $377M of Spectrum Pharmaceuticals Inc stock for Q4 2013, up 0.82% quarter-over-quarter.
  • 12 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2013 and 15 closed out, a net change of -3 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2013 was Royal Bank of Canada, an estimated $10.4M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2013 was D.E. Shaw & Co, an estimated $9.31M sold.

Based on aggregated 13F filings for Q4 2013.